Document ID: FDA-2009-N-0667-0013
Agency: fda
Document Type: Notice
Title: Memorandum of Understanding: United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Northeastern University
Posted Date: 2010-01-05T05:00Z

[Federal Register: January 5, 2010 (Volume 75, Number 2)]
[Notices]               
[Page 386-390]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05ja10-80]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0667]
[FDA 225-09-007]

 
Memorandum of Understanding Between the United States Department 
of Health and Human Services, Food and Drug Administration, Center for 
Drug Evaluation and Research and Northeastern University

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is providing notice of 
a Memorandum of Understanding (MOU) between FDA and Northeastern 
University. The purpose of the MOU is to form a collaborative 
relationship between FDA and Northeastern University; provide 
opportunities for exchanging of graduate and undergraduate students, 
faculty, and personnel and for advanced training and outreach; 
stimulate cooperative research, and information exchange in biological 
product characterization and regulation with Northeastern University's 
Barnett Institute of Chemical and Biological Analysis; and develop 
training programs for FDA and potentially other Government agencies and 
Industry in the broad areas of biotechnology and analytical chemistry.

DATES: The agreement became effective November 19, 2009.

FOR FURTHER INFORMATION CONTACT: Keith O. Webber, Office of 
Pharmaceutical Science, Center for Drug Evaluation and Research, Food 
and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 
20903, 301-796-2400, e-mail: Keith.webber@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which 
states that all written agreements and MOUs between FDA and others 
shall be published in the Federal Register, the agency is publishing 
notice of this MOU.

    Dated: December 17, 2009.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
BILLING CODE 4160-01-S

[[Page 387]]

[GRAPHIC] [TIFF OMITTED] TN05JA10.000

[[Page 388]]

[GRAPHIC] [TIFF OMITTED] TN05JA10.001

[[Page 389]]

[GRAPHIC] [TIFF OMITTED] TN05JA10.002

[[Page 390]]

[GRAPHIC] [TIFF OMITTED] TN05JA10.003

[FR Doc. E9-31195 Filed 1-4-10; 8:45 am]

BILLING CODE 4160-01-C